PR
PureTech Health plc
PRTC · NASDAQ
$17.42 -0.06% (-$0.01)
Market Cap $424.1M
P/E Ratio -
Div. Yield -
ROE 30.94%
Bulios Fair Price
$25.63
47.1% upside
Trenutna cena
$17.42
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PRTC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/B 1.36x
P/S 91.02x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 16.82%
Rev. growth 30.63%
FCF growth N/A
Profitability
20 /100
Weak Net margin 2,355.42%
Op. margin 2,114.72%
FCF margin 1,831.64%
Quality
0 /100
Poor ROE 30.94%
ROA 20.52%
Asset turnover 0.01x
Debt
69 /100
Low Current ratio 6.59x
Int. coverage -1.42x
Debt/Equity 0.06x
Stability
33 /100
Unstable Rev. volatility 32.92%
EPS volatility 1,433.04%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PRTC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert William Henry Lyne
Employees
56
Headquarters
Boston